Edimer Pharmaceuticals, Inc. — Form D
Edimer Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-07. The offering totals $18.0M, of which $9.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-08-07
- Form: D
- Accession: 0001466103-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $9.8M
- Remaining: $8.2M
- Investors: 5
- Date of first sale: 2013-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-200941
Issuer
- Name: Edimer Pharmaceuticals, Inc.
- CIK: 0001466103
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 55 Cambridge Parkway, Suite 102W, Cambridge, MA, 02142
- Phone: 617-758-4300
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| William Aliski | Director | Novato, CA |
| Wendy Dixon | Director | Cambridge, MA |
| Neil Kirby | Director | Cambridge, MA |
| David Mott | Director | Chevy Chase, MD |
| Cary Pfeffer | Director | Boston, MA |
| Mitchell Bloom | Executive Officer | Boston, MA |
| Neil Kirby | Executive Officer | Cambridge, MA |
More